Insider Makes Significant Stock buy in Fibrocell Science (FCSC) Shares Breaks neutral Trend of Last 90 Days

Wednesday, December 13, 2017 10:15 PM ET

Insider Makes Significant Stock buy in Fibrocell Science (FCSC) Shares Breaks neutral Trend of Last 90 Days

An insider — Randal J Kirk, 10% Owner — purchased 2,727,273 shares of Fibrocell Science having a market value of approximately $2,100,000 today, as disclosed in a form 4 document filed with the SEC. This is the first insider buy/sell trade in the past 90 days.

Fibrocell Science level of buy-sell trading activity is close to the 188 member peer company average. The Biotechnology & Medical Research peer group saw 164 buy/sell trades during this period for an average of 0.9 transactions per company. However, the number of shares per buy/sell trade transacted by Fibrocell Science insiders is higher. Within the peer group there were 24,420,851 shares purchased and 23,941,608 shares sold with company insiders acquiring 4,061 shares on average.

The data obtained in composing and writing in this story eliminates all trading activity reported to the SEC that involves awards, options, exercise of derivative securities, company buy-backs, taxes, gifts, shares acquired via inheritance and tenders or exchange offers.

Using proprietary Natural Language Generation (NLG) technology, UpTick evaluates corporate insider filings reported to the SEC and creates real-time news and analysis to report the most significant insider transactions based on transaction type, size and historical trends.

For more information, contact UpTick at info@uptickdata.com. Copyright 2017 UpTick Data Technologies. All rights reserved.

This entry was posted in InsiderNews and tagged , , , , . Bookmark the permalink.